Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
Anesa Mulabecirovic, Portfolio Manager at DNB Asset Management, shared a post on LinkedIn:
“The most common inherited bleeding disorder takes an average of sixteen years to diagnose in women.
Not because it is rare. It is not. The delay is about where the bleeding gets recorded.
A girl can bleed heavily from her first period, and the note that follows reads ‘heavy periods,’ not ‘possible clotting defect.’
She is routed to gynecology, not hematology. The symptom is counted. The disorder behind it is not.
Global registries identify von Willebrand disease in roughly 26 people per million.
Clinically significant disease runs closer to 1 in 1000.
Either way the treated population is a fraction of the real one, and the gap is a recording problem, not a biology one.
A market can only price what has a label.
The clinic meets the patient before the label exists, and that gap is larger than the numbers suggest.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026